ARA290 16mg
Erythropoietin-derived peptide fragment (Cibinetide), lyophilised powder (16mg, 99%+ purity) for in vitro research into tissue protection and regenerative signalling pathways.
Best value and fastest option — supplied as a lyophilised vial, shipped the same day when ordered by 1pm, Monday to Friday.
For In Vitro Use Only — Not for Human Use
Factory independent testing is reviewed for every batch, and we go the extra mile with our own independent HPLC & mass-spec testing in Europe. Where our certificate has been published, it is batch-numbered so you can match it to your vial.
Overview
ARA290 16mg is a synthetic peptide fragment derived from the erythropoietin receptor-binding domain, supplied as a lyophilised powder for laboratory research use. It is selected within controlled environments for investigation into tissue-protective signalling, receptor interaction, and regenerative pathway modelling.
Research
Within laboratory settings, ARA290 (Cibinetide) is studied for its interaction with the innate repair receptor and related protective signalling cascades. Research applications commonly focus on tissue protection, nerve-related pathway modelling, and cellular stress responses under controlled experimental conditions.
